Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHHAVI GUPTA

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1003052945
CMS profile
676781
Location
TAMPA, FL

General Payments · PY2018–2024

$4,111.68

  • Reported across 145 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,018.03

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,018.03 34

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $326.09 11
PY2019 $473.11 13
PY2020 $242.28 7
PY2021 $342.28 16
PY2022 $645.75 27
PY2023 $1,064.14 37
PY2024 $1,018.03 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $29.50 01/09/2024 Food and Beverage Undisputed 01/23/2026 1117268137 CMS
Amgen Inc. $34.82 07/18/2024 Food and Beverage Undisputed 01/23/2026 1117268139 CMS
Ardelyx, Inc. $26.72 01/23/2024 Food and Beverage Undisputed 01/23/2026 1146683297 CMS
Ardelyx, Inc. $28.38 07/25/2024 Food and Beverage Undisputed 01/23/2026 1146683299 CMS
AstraZeneca Pharmaceuticals LP $33.88 02/06/2024 Food and Beverage Undisputed 01/23/2026 1104784604 CMS
Bayer Healthcare Pharmaceuticals Inc. $25.88 01/25/2024 Food and Beverage Undisputed 01/23/2026 1086185154 CMS
Bayer Healthcare Pharmaceuticals Inc. $27.79 07/09/2024 Food and Beverage Undisputed 01/23/2026 1086128742 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.07 09/17/2024 Food and Beverage Undisputed 01/23/2026 1086132284 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.42 02/22/2024 Food and Beverage Undisputed 01/23/2026 1117831029 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 04/30/2024 Food and Beverage Undisputed 01/23/2026 1117831035 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 08/06/2024 Food and Beverage Undisputed 01/23/2026 1117831037 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $90.51 08/27/2024 Food and Beverage Undisputed 01/23/2026 1117831031 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 09/24/2024 Food and Beverage Undisputed 01/23/2026 1117831039 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $34.85 11/07/2024 Food and Beverage Undisputed 01/23/2026 1117831033 CMS
CorMedix Inc. $25.45 05/29/2024 Food and Beverage Undisputed 01/23/2026 1082024199 CMS
GlaxoSmithKline, LLC. $26.55 02/13/2024 Food and Beverage Undisputed 01/23/2026 1116085290 CMS
Lilly USA, LLC $31.38 07/30/2024 Food and Beverage Undisputed 01/23/2026 1136097728 CMS
Mallinckrodt Hospital Products Inc. $28.48 03/28/2024 Food and Beverage Undisputed 01/23/2026 1145079564 CMS
Mallinckrodt Hospital Products Inc. $30.22 08/30/2024 Food and Beverage Undisputed 01/23/2026 1145079569 CMS
Novartis Pharmaceuticals Corporation $33.39 02/29/2024 Food and Beverage Undisputed 01/23/2026 1086926555 CMS
Novartis Pharmaceuticals Corporation $13.71 06/04/2024 Food and Beverage Undisputed 01/23/2026 1086926565 CMS
Novartis Pharmaceuticals Corporation $22.72 08/22/2024 Food and Beverage Undisputed 01/23/2026 1086926575 CMS
Novartis Pharmaceuticals Corporation $24.80 11/19/2024 Food and Beverage Undisputed 01/23/2026 1086926593 CMS
Otsuka America Pharmaceutical, Inc. $25.66 01/16/2024 Food and Beverage Undisputed 01/23/2026 1118902750 CMS
Otsuka America Pharmaceutical, Inc. $27.40 03/05/2024 Food and Beverage Undisputed 01/23/2026 1118902752 CMS
Otsuka America Pharmaceutical, Inc. $28.18 04/25/2024 Food and Beverage Undisputed 01/23/2026 1118902754 CMS
Otsuka America Pharmaceutical, Inc. $21.59 08/20/2024 Food and Beverage Undisputed 01/23/2026 1118902756 CMS
Otsuka America Pharmaceutical, Inc. $29.69 10/02/2024 Food and Beverage Undisputed 01/23/2026 1118902758 CMS
Otsuka America Pharmaceutical, Inc. $23.14 11/12/2024 Food and Beverage Undisputed 01/23/2026 1118902760 CMS
Travere Therapeutics, Inc. $26.33 01/31/2024 Food and Beverage Undisputed 01/23/2026 1149902218 CMS
Travere Therapeutics, Inc. $26.23 04/09/2024 Food and Beverage Undisputed 01/23/2026 1149902214 CMS
Travere Therapeutics, Inc. $28.89 06/06/2024 Food and Beverage Undisputed 01/23/2026 1149902226 CMS
Travere Therapeutics, Inc. $35.54 09/03/2024 Food and Beverage Undisputed 01/23/2026 1149902230 CMS
Travere Therapeutics, Inc. $28.86 11/26/2024 Food and Beverage Undisputed 01/23/2026 1149902222 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.